We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EL icon
51
Estee Lauder
EL
$29B
$24.2M 0.37%
186,023
+46,419
+33% +$6.31M
ARRY
52
DELISTED
Array Biopharma Inc
ARRY
$23.9M 0.37%
1,678,710
+327,522
+24% +$4.97M
CI icon
53
Cigna
CI
$76.6B
$22.7M 0.35%
119,721
-44,678
-27% -$9.32M
SHW icon
54
Sherwin-Williams
SHW
$78.3B
$22.3M 0.34%
170,106
-3,633
-2% -$490K
WFC icon
55
Wells Fargo
WFC
$261B
$22M 0.34%
477,596
-2,415
-0.5% -$124K
ISRG icon
56
Intuitive Surgical
ISRG
$121B
$22M 0.34%
137,838
-34,563
-20% -$5.86M
TSM icon
57
TSMC
TSM
$2.09T
$21.6M 0.33%
585,686
+123,803
+27% +$4.71M
HCA icon
58
HCA Healthcare
HCA
$84.8B
$21.5M 0.33%
172,946
+27,451
+19% +$3.68M
ALL icon
59
Allstate
ALL
$66.9B
$21.4M 0.33%
259,379
-13,699
-5% -$1.23M
ADSK icon
60
Autodesk
ADSK
$44.3B
$21M 0.32%
163,432
-29,612
-15% -$4M
PEP icon
61
PepsiCo
PEP
$186B
$20.8M 0.32%
188,019
-47,304
-20% -$5.33M
ALNY icon
62
Alnylam Pharmaceuticals
ALNY
$36.3B
$20.8M 0.32%
284,701
+53,491
+23% +$4.11M
ONC
63
BeOne Medicines Ltd
ONC
$33.8B
$20.7M 0.32%
147,788
+47,488
+47% +$6.3M
BHVN
64
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$20.3M 0.31%
547,799
+130,500
+31% +$4.71M
EMR icon
65
Emerson Electric
EMR
$82.9B
$20M 0.31%
334,597
-6,860
-2% -$463K
PFE icon
66
Pfizer
PFE
$140B
$19.8M 0.3%
478,567
-89,484
-16% -$3.71M
CTXS
67
DELISTED
Citrix Systems Inc
CTXS
$19.8M 0.3%
193,134
-9,276
-5% -$980K
BAP icon
68
Credicorp
BAP
$30.9B
$19.6M 0.3%
88,300
-13,500
-13% -$2.98M
TMO icon
69
Thermo Fisher Scientific
TMO
$211B
$19.6M 0.3%
87,406
+7,788
+10% +$1.83M
UPS icon
70
United Parcel Service
UPS
$97.6B
$19.5M 0.3%
200,025
+30,074
+18% +$3.26M
UNP icon
71
Union Pacific
UNP
$183B
$19.5M 0.3%
141,055
-7,319
-5% -$1.08M
PTC icon
72
PTC
PTC
$13.7B
$19.4M 0.3%
234,542
-105,905
-31% -$9.3M
CVX icon
73
Chevron
CVX
$388B
$19.4M 0.3%
178,011
+3,072
+2% +$356K
ELV icon
74
Elevance Health
ELV
$81.9B
$18.8M 0.29%
71,475
+5,848
+9% +$1.61M
TRMB icon
75
Trimble
TRMB
$12.3B
$18.7M 0.29%
567,094
+259,435
+84% +$9.55M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.